Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Catching the Clinical Genomics Wave

Catching the Clinical Genomics Wave

Jul 01, 2001
Premium

By Jennifer Friedlin

Following its market debut in February, Third Wave Technologies did not have the most auspicious post-IPO performance. But since the end of April the Madison, Wis.-based maker of the Invader SNP-detection system has been generating some ripples.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

National Academy of Sciences May Expel Members

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

More to Mix and Match

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

Nucleic Acids Research Papers on DNA-Bound Proteins, Transcriptional Activation, More

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

Pause Recommended

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.